In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 25 for your search:
Cancer Type/Condition:  Endometrial cancer
Stage/Subtype:  stage III endometrial cancer
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GOG-0286B, NCI-2013-02284, U10CA027469, NCT02065687

2.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and older
Sponsor: NCI, Other
Protocol IDs: GOG-0258, NCI-2011-01951, CDR0000649079, U10CA027469, NCT00942357

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 1203, CDR0000738944, NCI-2012-02001, NCT01672892

4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AEZS -108-050, NCT01767155

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-20025/20288, NCT01580696

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ISS22810034, NCT01650376

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MMC-08-03-060, NCT01041027

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 1012007786, NCT01367002

9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2012-0543, NCI-2013-00960, NCT01797523

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 13-02-058, NCI-2013-01226, P30CA013330, NCT02112552

11.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ATDTRPST0802, NCT00800345

12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 110022, 11-C-0022, NCT01237067

13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 110061, 11-C-0061, NCT01273168

14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02500, CDR0000700997, UPCI-10-115, 8808, U01CA099168, U01CA062490, U01CA070095, U01CA069856, U01CA062505, U01CA062502, P30CA047904, NCT01366144

15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 115717, NCT01458067

16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: PM1183-A-007-13, NCT01831089

17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2014-01118, 14-079, 9552, UM1CA186712, P30CA006516, U01CA076576, UM1CA186709, U01CA062490, NCT02142803

18.

Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2003-0529, NCT00394602

19.

Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 to 90
Sponsor: NCI
Protocol IDs: 090100, 09-C-0100, NCT00924027

20.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-03275, CDR0000712251, MDA-2011-0252, 2011-0252, 8836, P30CA016672, P50CA098258, NCT01440998

21.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: 15809, NCT01482728

22.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 10-269, NCT01600040

23.

Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CASE9813, NCI-2013-01309, P30CA043703, NCT01939028

24.

Phase: No phase specified
Type: Supportive care, Treatment
Status: Active
Age: 18 and older
Sponsor: NCI, Other
Protocol IDs: 09-12-392, NCI-2013-01127, 09-068, P30CA013330, NCT01939210

25.

Phase: No phase specified
Type: Tissue collection/Repository, Treatment
Status: Active
Age: 18 and older
Sponsor: NCI, Other
Protocol IDs: 12316, NCI-2013-01948, NCT01970722
New Search